Therefore, we hypothesized that ESM1 may be a downstream molecule of TNFα that mediates bevacizumab resistance and further verified whether ESM1 was highly expressed in bevacizumab-resistant tumor tissues or cells. The gene discussed is TNF; the disease is neoplasm.